Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in ...

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.

Wegovy prescriptions jumped 33%, but experts say Novo Nordisk must prove its growth is sustainable beyond the ban on rivals ...

Learn about safely stopping Wegovy (semaglutide), what effects it may have on your body, and ways to keep the weight off after stopping treatment.

Wegovy (semaglutide) is an injectable medication that’s approved for weight loss. Due to its popularity, fake or counterfeit Wegovy products are on the market.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.

Novo Nordisk seeks EMA approval for 7.2 mg Wegovy dose after trials show 21% weight loss in people with obesity and type 2 diabetes.

Global health company The Cigna Group completed its fourth round of layoffs this year at its New Jersey-based subsidiary Cigna Evernorth Health Services last week. Evernorth, which provides ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy.

Popular diabetes and weight loss drug, semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. The corresponding study was published in ...